Homerun Resources Inc is engaged in the exploration and development of minerals. The company's project is the Homathko Gold Project situated in Canada. The company has one reportable segment: exploration and evaluation of mineral properties. The company's assets are located in Canada. It has two reportable operating segments, being that its corporate headquarters is located in Canada and its operations in Brazil.
相关临床试验
0
0 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
N/A
暂无试验阶段数据
暂无试验数据
暂无试验数据
暂无批准数据
- Nucleus Network has acquired Hammersmith Medicines Research (HMR), establishing the only early-phase clinical research provider with dedicated facilities across Australia, the United States, and the United Kingdom. - The acquisition creates a fully integrated global platform that enables studies to commence in one regulatory environment and seamlessly transition to another, accelerating timelines and reducing operational risk. - The combined organization expands access to broader and more diverse volunteer and patient populations, supporting faster recruitment and more inclusive study designs critical for first-in-human and adaptive trial protocols. - With over 20 years of experience and more than 1,500 first-in-human studies conducted, the expanded network strengthens capabilities for delivering early-phase clinical trials across three continents.
- Small pharmaceutical companies are increasingly adopting adaptive clinical trials that allow protocol modifications based on interim data, offering flexibility to adjust doses or participant sample sizes during studies. - On-demand manufacturing provides real-time supply and demand adjustments to address the logistical complexities of adaptive trials while maintaining regulatory compliance. - This manufacturing approach enables pharmaceutical firms to align production with evolving trial requirements, reducing risks of overproduction or undersupply during dynamic early-stage research efforts.
